JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
JNCE
Delisted
JNCE was delisted on the 3rd of May, 2023.
90 hedge funds and large institutions have $180M invested in Jounce Therapeutics, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 29 increasing their positions, 32 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
90
Holders Change
+2
Holders Change %
+2.27%
% of All Funds
1.85%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
13
Increased
29
Reduced
32
Closed
11
Calls
$639K
Puts
$128K
Net Calls
+$511K
Net Calls Change
+$279K
